BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24894198)

  • 1. Dihydromyricetin activates AMP-activated protein kinase and P38(MAPK) exerting antitumor potential in osteosarcoma.
    Zhao Z; Yin JQ; Wu MS; Song G; Xie XB; Zou C; Tang Q; Wu Y; Lu J; Wang Y; Wang J; Kang T; Jia Q; Shen J
    Cancer Prev Res (Phila); 2014 Sep; 7(9):927-38. PubMed ID: 24894198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
    Yang R; Piperdi S; Gorlick R
    Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydromyricetin ameliorates the oxidative stress response induced by methylglyoxal via the AMPK/GLUT4 signaling pathway in PC12 cells.
    Jiang B; Le L; Pan H; Hu K; Xu L; Xiao P
    Brain Res Bull; 2014 Oct; 109():117-26. PubMed ID: 25451453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin-Induced Apoptosis in Osteosarcoma Cells: A Key Role of RhoA-AMPK/p38 MAPK Signaling in Antitumor Activity.
    Kamel WA; Sugihara E; Nobusue H; Yamaguchi-Iwai S; Onishi N; Maki K; Fukuchi Y; Matsuo K; Muto A; Saya H; Shimizu T
    Mol Cancer Ther; 2017 Jan; 16(1):182-192. PubMed ID: 27799356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydromyricetin from Ampelopsis grossedentata inhibits melanogenesis through down-regulation of MAPK, PKA and PKC signaling pathways.
    Huang HC; Liao CC; Peng CC; Lim JM; Siao JH; Wei CM; Chen CC; Wu CS; Chang TM
    Chem Biol Interact; 2016 Oct; 258():166-74. PubMed ID: 27586645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glabridin inhibits osteosarcoma migration and invasion via blocking the p38- and JNK-mediated CREB-AP1 complexes formation.
    Jie Z; Xie Z; Zhao X; Sun X; Yu H; Pan X; Shen S; Qin A; Fang X; Fan S
    J Cell Physiol; 2019 Apr; 234(4):4167-4178. PubMed ID: 30146723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of a nitrogen-containing bisphosphonate, minodronate, in conjunction with a p38 mitogen activated protein kinase inhibitor or doxorubicin against malignant bone tumor cells.
    Kubo T; Shimose S; Matsuo T; Sakai A; Ochi M
    Cancer Chemother Pharmacol; 2008 Jun; 62(1):111-6. PubMed ID: 17874104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel antitumor piperazine alkyl compound causes apoptosis by inducing RhoB expression via ROS‑mediated c‑Abl/p38 MAPK signaling.
    Chung KS; Han G; Kim BK; Kim HM; Yang JS; Ahn J; Lee K; Song KB; Won M
    Cancer Chemother Pharmacol; 2013 Dec; 72(6):1315-24. PubMed ID: 24121479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase 1/2.
    Chang HL; Wu YC; Su JH; Yeh YT; Yuan SS
    J Pharmacol Exp Ther; 2008 Jun; 325(3):841-9. PubMed ID: 18337475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-Methoxydalbergione suppresses growth and induces apoptosis in human osteosarcoma cells in vitro and in vivo xenograft model through down-regulation of the JAK2/STAT3 pathway.
    Park KR; Yun HM; Quang TH; Oh H; Lee DS; Auh QS; Kim EC
    Oncotarget; 2016 Feb; 7(6):6960-71. PubMed ID: 26755649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bortezomib induces apoptosis and autophagy in osteosarcoma cells through mitogen-activated protein kinase pathway in vitro.
    Lou Z; Ren T; Peng X; Sun Y; Jiao G; Lu Q; Zhang S; Lu X; Guo W
    J Int Med Res; 2013 Oct; 41(5):1505-19. PubMed ID: 23975859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gallic acid induces the apoptosis of human osteosarcoma cells in vitro and in vivo via the regulation of mitogen-activated protein kinase pathways.
    Liang CZ; Zhang X; Li H; Tao YQ; Tao LJ; Yang ZR; Zhou XP; Shi ZL; Tao HM
    Cancer Biother Radiopharm; 2012 Dec; 27(10):701-10. PubMed ID: 22849560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 upregulation in osteosarcoma preclinical models.
    Pignochino Y; Dell'Aglio C; Basiricò M; Capozzi F; Soster M; Marchiò S; Bruno S; Gammaitoni L; Sangiolo D; Torchiaro E; D'Ambrosio L; Fagioli F; Ferrari S; Alberghini M; Picci P; Aglietta M; Grignani G
    Clin Cancer Res; 2013 Apr; 19(8):2117-31. PubMed ID: 23434734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardamonin inhibits the growth of human osteosarcoma cells through activating P38 and JNK signaling pathway.
    Zhang L; Yang C; Huang Y; Huang H; Yuan X; Zhang P; Ye C; Wei M; Wang Y; Luo X; Luo J
    Biomed Pharmacother; 2021 Feb; 134():111155. PubMed ID: 33370628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel synthesized 6-fluoro-(3-fluorophenyl)-4-(3-methoxyanilino)quinazoline (LJJ-10) compound exhibits anti-metastatic effects in human osteosarcoma U-2 OS cells through targeting insulin-like growth factor-I receptor.
    Chen KT; Hour MJ; Tsai SC; Chung JG; Kuo SC; Lu CC; Chiu YJ; Chuang YH; Yang JS
    Int J Oncol; 2011 Sep; 39(3):611-9. PubMed ID: 21667022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting GSTP1-1 induces JNK activation and leads to apoptosis in cisplatin-sensitive and -resistant human osteosarcoma cell lines.
    Sau A; Filomeni G; Pezzola S; D'Aguanno S; Tregno FP; Urbani A; Serra M; Pasello M; Picci P; Federici G; Caccuri AM
    Mol Biosyst; 2012 Apr; 8(4):994-1006. PubMed ID: 22068640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetramethylpyrazine inhibits osteosarcoma cell proliferation via downregulation of NF-κB in vitro and in vivo.
    Wang Y; Fu Q; Zhao W
    Mol Med Rep; 2013 Oct; 8(4):984-8. PubMed ID: 23912183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.
    Wang SW; Liu SC; Sun HL; Huang TY; Chan CH; Yang CY; Yeh HI; Huang YL; Chou WY; Lin YM; Tang CH
    Carcinogenesis; 2015 Jan; 36(1):104-14. PubMed ID: 25330803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BMP9/p38 MAPK is essential for the antiproliferative effect of resveratrol on human colon cancer.
    Yuan SX; Wang DX; Wu QX; Ren CM; Li Y; Chen QZ; Zeng YH; Shao Y; Yang JQ; Bai Y; Zhang P; Yu Y; Wu K; Sun WJ; He BC
    Oncol Rep; 2016 Feb; 35(2):939-47. PubMed ID: 26555012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumour effects of Yangzheng Xiaoji in human osteosarcoma: the pivotal role of focal adhesion kinase signalling.
    Jiang WG; Ye L; Ji K; Ruge F; Wu Y; Gao Y; Ji J; Mason MD
    Oncol Rep; 2013 Sep; 30(3):1405-13. PubMed ID: 23828123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.